Clinical Trial Update: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL [Phase 2]

View source ↗

Summary

A randomized Phase II trial is comparing oral azacitidine plus romidepsin against investigator's choice in peripheral T-cell lymphoma and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Romidepsin (romidepsin)

Snippet

Sponsor: University of Virginia | Conditions: PTCL | Phase 2 | Status: RECRUITING